Its peripheral vascular effect has indicated its use for vertigo, dyslexia and, at one time, sickle cell anemia as well, but a subsequent Cochrane review of the evidence found that it did not support piracetam's use in sickle cell crisis prevention.
Its peripheral vascular effect has indicated its use for vertigo, dyslexia and sickle cell anemia as well. This was at one time. It did not support piracetam's use in sickle cell crisis prevention. A subsequent Cochrane review of the evidence found this.